Stroke:
From Bench to Bedside
Diseases of Aging -
3
ASPET-Ray Fuller Symposium
April 10-11,
2003
San Diego Marriott Hotel and Marina
Marriott Hall 2 (in the Pavilioin)
San Diego, California, USA
Organized by:
Roberto Levi, Cornell University and David J. Pinsky,
University of Michigan
SESSION I: CURRENT PHARMACOLOGICAL TREATMENT OF STROKE: ARE THE HURDLES INSURMOUNTABLE?
SESSION II: VASCULAR COMPROMISE AND NEURONAL DEMISE IN STROKE
Friday, April 11
SESSION III: STROKE THERAPY: EYE TOWARDS THE FUTURE
Primate stroke: interface between mice and men. E. Sander Connolly, Columbia Univ.
Nonpharmacologic approaches to stroke therapy. Hemicraniectomy: when more is less. Jeffrey I. Frank, Univ. of Chicago
Roles of hypothermia and albumin as non-pharmacologic approaches to stroke therapy. Myron D. Ginsberg, Univ. of Miami
Non-pharmacologic approach to stroke therapy: role of growth factors and stem cells. Seth Finklestein, ViaCell, Inc.
Stroke therapy: the pharmacological future. Giora Z. Feuerstein, Merck Research Laboratories
Eight (8) Category 1
CME credits toward the American Medical Association Physician’s
Recognition Award will be offered at this meeting.
Satellite Meeting to Experimental Biology 2003 – Separate Registration Required